BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12672055)

  • 1. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.
    Varadaradjalou S; Féger F; Thieblemont N; Hamouda NB; Pleau JM; Dy M; Arock M
    Eur J Immunol; 2003 Apr; 33(4):899-906. PubMed ID: 12672055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4-mediated activation of murine mast cells.
    McCurdy JD; Lin TJ; Marshall JS
    J Leukoc Biol; 2001 Dec; 70(6):977-84. PubMed ID: 11739561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria.
    Laflamme N; Echchannaoui H; Landmann R; Rivest S
    Eur J Immunol; 2003 Apr; 33(4):1127-38. PubMed ID: 12672079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
    Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
    Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MD-2 is required for the full responsiveness of mast cells to LPS but not to PGN.
    Ushio H; Nakao A; Supajatura V; Miyake K; Okumura K; Ogawa H
    Biochem Biophys Res Commun; 2004 Oct; 323(2):491-8. PubMed ID: 15369778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation.
    Liu Y; Wang Y; Yamakuchi M; Isowaki S; Nagata E; Kanmura Y; Kitajima I; Maruyama I
    Infect Immun; 2001 May; 69(5):2788-96. PubMed ID: 11292690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion.
    Bieneman AP; Chichester KL; Chen YH; Schroeder JT
    J Allergy Clin Immunol; 2005 Feb; 115(2):295-301. PubMed ID: 15696084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity.
    Supajatura V; Ushio H; Nakao A; Akira S; Okumura K; Ra C; Ogawa H
    J Clin Invest; 2002 May; 109(10):1351-9. PubMed ID: 12021251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialyzable leukocyte extract differentially regulates the production of TNFalpha, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells.
    Ojeda MO; van't Veer C; Fernández Ortega CB; Araña Rosainz Mde J; Buurman WA
    Inflamm Res; 2005 Feb; 54(2):74-81. PubMed ID: 15750714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of Toll-like receptors in chicken heterophils.
    Kogut MH; Iqbal M; He H; Philbin V; Kaiser P; Smith A
    Dev Comp Immunol; 2005; 29(9):791-807. PubMed ID: 15936435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monocytoid cells as a model to study Toll-like receptor-mediated activation.
    Remer KA; Brcic M; Sauter KS; Jungi TW
    J Immunol Methods; 2006 Jun; 313(1-2):1-10. PubMed ID: 16720029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2.
    Pridmore AC; Wyllie DH; Abdillahi F; Steeghs L; van der Ley P; Dower SK; Read RC
    J Infect Dis; 2001 Jan; 183(1):89-96. PubMed ID: 11076707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
    Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
    Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.
    Mirlashari MR; Lyberg T
    Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4.
    Stewart LK; Flynn MG; Campbell WW; Craig BA; Robinson JP; McFarlin BK; Timmerman KL; Coen PM; Felker J; Talbert E
    Brain Behav Immun; 2005 Sep; 19(5):389-97. PubMed ID: 15963685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-anchored CD14 is important for induction of interleukin-8 by lipopolysaccharide and peptidoglycan in uroepithelial cells.
    Shimizu T; Yokota S; Takahashi S; Kunishima Y; Takeyama K; Masumori N; Takahashi A; Matsukawa M; Itoh N; Tsukamoto T; Fujii N
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):969-76. PubMed ID: 15358661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.